Category Archives: AZBio News
AZBio and RESI Partner on Free Audience Pass for AZBio Members at RESI Digital in March 2023
Arizona Bioindustry Association (AZBio) Partners with Digital RESI March 14-16th Offering “Seeing is Believing”
FREE Audience Access Pass to Members
Continue reading
How You Can Impact Arizona’s Innovation Future
Grass roots advocacy is when people engage in the legislative process by sharing their views with their elected leaders. It can take the form of writing or signing on to letters, testifying at hearings, attending town halls, visiting an elected leader at their office; or, here in Arizona, sharing their position on bills at the Legislature using the Request to Speak System. Continue reading
Funding for the Arizona Health Innovation Trust Fund Passes in Senate Appropriations
The Arizona Health Innovation Trust Fund (AHIT) was established in 2022 to develop workforce programs; support small health innovation businesses; and provide other financial support that will drive growth in Arizona’s life science sector. On February 23, 2023, SB1084 was amended to appropriate $50 million in funding for AHIT in Arizona’s FY24 budget and declares that the Legislature intends that the Fund steadily grows to maintain a permanent endowment balance of at least $200 million. The amended bill received a Do Pass as Amended recommendation. SB1084 now moves to consideration by the Senate Rules Committee.Continue reading
Updates to Arizona’s R and D Tax Credits Under Consideration at Arizona Legislature
On February 23,2023, the Arizona Senate Appropriations gave a Do Pass Recommendation to SB1562 which updates and expands Arizona’s R&D Tax Credit program.Continue reading
On the rise in 2023: Six Arizona bioscience startups
Phoenix area, Tucson companies selected for Flinn Foundation program
A record 48 firms applied for our program this year—a testament to Arizona’s vibrant bioscience startup culture.Continue reading
Health Catalysts Group Releases Annual HCG Diagnostics Year In Review for 2022
The HCG Diagnostics Year in Review for 2022 contains data related to clinical diagnostics and diagnostics in the public markets, with special attention to the MEGA Index, diagnostic company IPOs, and diagnostic M&A. This report also includes Arizona State University’s Testing Commons COVID Year in Review, which focuses on all things related to SARS-CoV-2 diagnostics as well as COVID incidence vs influence and a history of the COVID mutations in the US.Continue reading
Exact Sciences Launches OncoExTra™ Cancer Therapy Selection Test in the U.S.
On Thursday, February 16, 2023, Kevin Conroy, chairman and CEO of Exact Sciences keynoted the TGen’s Arizona Bioscience Impact breakfast and shared his belief in the powerful impact of early detection in saving lives and improving cancer care. He also introduced the audience to Exact Sciences newest diagnostic innovation – OncoExTra.Continue reading
ASU’s Biodesign Institute blazes new research trails
Stream of funding spurs advances in human health:
Arizona State University Biodesign Institute researchers have received three significant new grants, advancing knowledge of digestive proteins in the human gut, toxic exposure to fungi during childhood and long-term vaccine effectiveness. Continue reading